English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Clinical Trials
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Apr 18, 2023 11:00 HKT
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Apr 17, 2023 19:30 HKT
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
Apr 14, 2023 17:18 HKT
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
Apr 11, 2023 12:58 HKT
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50%
Apr 11, 2023 08:00 HKT
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
Mar 30, 2023 20:29 HKT
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
Mar 21, 2023 08:30 HKT
Essex Bio-Technology Announces 2022 Annual Financial Results
Mar 08, 2023 20:28 HKT
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Feb 22, 2023 18:48 HKT
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
Feb 15, 2023 09:00 HKT
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Feb 10, 2023 21:06 HKT
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Feb 10, 2023 19:00 HKT
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Jan 12, 2023 15:00 HKT
Novotech Acquires European CRO, Strengthens Global Operations
Jan 12, 2023 15:00 HKT
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
Jan 11, 2023 21:00 HKT
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program
Jan 11, 2023 15:00 HKT
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Jan 05, 2023 18:00 HKT
Novotech is Gold Sponsor at Biotech Showcase 2023
Dec 20, 2022 11:00 HKT
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: